Evaluating Medically Coordinated Care Programs for Autism Spectrum Disorders

Researchers at Aix-Marseille University conducted a retrospective study to evaluate the effectiveness of medically coordinated care programs for children with autism spectrum disorders (ASD). The study compared the outcomes of 20 ASD children receiving care in a medically coordinated care program (MHCC) versus a day care hospital (DCH). The results showed that both groups exhibited improvements in autism severity and socio-adaptive behavior, but the MHCC group had a statistically significant reduction in autism severity.

Key Takeaways:

  • The study compared the outcomes of 20 ASD children receiving care in a medically coordinated care program (MHCC) versus a day care hospital (DCH).
  • Both groups exhibited improvements in autism severity and socio-adaptive behavior.
  • The MHCC group had a statistically significant reduction in autism severity compared to the DCH group.
  • The study suggests that medically coordinated care programs in MHCCs can be an effective alternative to DCHs for children with ASD.
  • The research highlights the need for further multicenter studies to demonstrate the non-inferiority of coordinated care programs in MHCCs versus DCHs.
  • The study found that the continuation of this research work could provide more precise indications concerning the relevance of each treatment.
  • The study included 20 ASD children divided into two groups: DCH and MHCC.
  • The DCH group received care in a day hospital with individual educational care, while the MHCC group benefited from a medically coordinated care program.
  • The composite criterion used to compare the outcomes of the two groups was a combination of CARS-2 and VABS-II scores.
  • The study had a non-inferiority threshold of 10% of the initial value of each score.

Statistics:

  • 20 ASD children were included in the study.
  • 10 children received care in the DCH group.
  • 10 children received a medically coordinated care program in the MHCC group.
  • The MHCC group had a statistically significant reduction in autism severity compared to the DCH group (p < 0.05).
  • The study found that both groups exhibited improvements in socio-adaptive behavior, but the trend was more pronounced in the MHCC group (VABS-II scores).

Sources:

  • L Encephale (2024), Evaluation of a medically coordinated care program in the management of autism.
  • Aix-Marseille University, France, NewsRx (2024), Pediatrics Week, July 27, 2024.